Medix Biochemica expands antibody offering with ViroStat acq

Medix Biochemica expands antibody offering with ViroStat acquisition

Medix Biochemicals has acquired ViroStat in an effort to provide its customers with infectious disease antibodies and antigens for their IVD immunoassay test development.

Related Keywords

Maine , United States , Douglas Mcallister , Duncan Mcallister , Medix Biochemica , Steve Ferguson , , Markets Amp Regulations , Pipelines , Emerging Markets , Infectious Disease , Ntibody , Antigens ,

© 2025 Vimarsana